PregnancyNCT07134959
Exercise Benefits and Barriers in Pregnancy
An observational study of Pregnancy, run by Ordu University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to examine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women. It will contribute to raising awareness about engaging in physical activity and exercise during pregnancy in the pregnant population through the applied questionnaires. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pregnancy
- How many people
- 300 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2025to 1 Dec 2025
- How long will I take part?
- 5 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Ordu University Training and Research Hospital
Who may be able to join
- Being between 18 and 45 years of age,
- Being in the second or third trimester of pregnancy,
- Being literate in Turkish,
- Willingness to participate in the study.
- Being between 18 and 45 years of age,
- Female sex,
- Being literate in Turkish,
- Willingness to participate in the study.
Who cannot join
- Presence of pregnancy complications that may prevent physical activity and exercise (e.g., preeclampsia, vaginal bleeding, heart disease),
- Presence of orthopedic or neurological problems that may hinder participation in the study,
- Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
- Multiple pregnancy.
- Having a disease severe enough to prevent physical activity and exercise (e.g., endocrine and metabolic disorders, cardiopulmonary diseases),
- Presence of orthopedic or neurological problems that may hinder participation in the study,
Show all 10Show fewer
- Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
- Participation in another experimental or drug study during the study period,
- Being pregnant or suspected of pregnancy,
- Having experienced pregnancy, childbirth, or surgical intervention within the last six months.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Validity and Reliability of Turkish Version Exercise Benefits/Barriers Scale in Pregnant Women
The aim of this study is to examine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women. It will contribute to raising awareness about engaging in physical activity and exercise during pregnancy in the pregnant population through the applied questionnaires.
Read the detailed description
Regular physical activity (PA) and exercise during pregnancy help protect the health of both the mother and the baby by reducing the risk of excessive gestational weight gain, hypertension, gestational diabetes, venous problems, and birth-related complications. They also have positive effects on sleep, stress, anxiety, depression, and overall quality of life. However, PA participation rates during pregnancy are low and tend to decline as pregnancy progresses through the trimesters. Hormonal and physiological changes, weight gain, fatigue, and psychological disturbances are among the main factors limiting participation. Therefore, identifying the barriers to PA during pregnancy and developing strategies to address them is essential. Assessing perceptions of the benefits and barriers to exercise can guide interventions aimed at increasing PA levels. This study aims to determine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women, with the expectation that its findings will provide valuable evidence for both scientific research and clinical practice.
- Conditions
- Pregnancy
- Keywords
- pregnancy, exercise, Questionnaire, physical activity
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| study group | pregnant women | |
| control group | healthy non-pregnant women |
What is being measured
The primary outcome is the main question the study is designed to answer.
Exercise Benefits/Barriers Scale (EBBS):
Developed in 1987 by Sechrist et al. to assess individuals' perceptions of the benefits of and barriers to exercise (Sechrist et al., 1987). It is a Likert-type scale with responses rated from "4 = strongly agree" to "1 = strongly disagree." The scale consists of two subscales: EBBS-Benefits and EBBS-Barriers. The EBBS-Benefits subscale contains 29 items, while the EBBS-Barriers subscale contains 14 items. In the EBBS-Barriers subscale, lower scores indicate a higher perceived barrier to exercise, whereas in the EBBS-Benefits subscale, higher scores indicate a more positive perception of exercise. The validity and reliability of the Turkish version were demonstrated by Saraç et al. (2024), with Cronbach's alpha coefficients of 0.95 for the EBBS-Benefits subscale and 0.82 for the EBBS-Barriers subscale (Saraç et al., 2024).
Measured: At baseline and 5 days after the first assessment
Secondary outcomes (5)
Barriers to Physical Activity During Pregnancy Scale
Developed by Amiri-Farahani et al. (2021) to evaluate barriers to physical activity among pregnant women. The scale consists of 29 items and four subdimensions, with each item scored on a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). Higher scores indicate greater barriers to physical activity (Amiri-Farahani et al., 2021). The validity and reliability of the Turkish version were confirmed by Ataman Bor and Hanligil, with Cronbach's alpha coefficients reported as follows: total scale, 0.91; pregnancy-related personal barriers, 0.88; non-pregnancy-related personal barriers, 0.89; interpersonal barriers, 0.87; environmental barriers, 0.80 (Bor \& Hanligil, 2024).
Measured: at baseline
Pregnancy Physical Activity Questionnaire (PPAQ)
Developed by Chasan-Taber et al. (2004), this semi-quantitative questionnaire asks participants to report the amount of time spent on 32 different activities. These include household/caregiving activities (13 items), occupational activities (5 items), sports/exercise (8 items), transportation (3 items), and inactivity (3 items). For each activity, participants indicate the amount of time they typically spend per day or week during their current trimester. Time intervals range from 0 to 6 or more hours per day and 0 to 3 or more hours per week. An open-ended section at the end allows participants to list other activities not included in the questionnaire. Weekly total energy expenditure is calculated as MET-hours/week (Chasan-Taber et al., 2004). The Turkish validity and reliability study was conducted by Çırak et al. (2015).
Measured: at baseline
International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Physical activity levels will be assessed using the Turkish version of the IPAQ-SF, which has demonstrated validity and reliability (Saglam et al., 2010). The questionnaire consists of seven items evaluating time spent in walking, moderate-intensity, and vigorous-intensity activities, as well as one separate question assessing time spent sitting. Scoring involves calculating total minutes and days for walking, moderate, and vigorous activities. MET-minutes are computed by multiplying the minutes spent in each activity by its MET value (vigorous activity = 8 METs, moderate activity = 4 METs, walking = 3.3 METs). Participants are classified into three categories based on total MET-minutes: "inactive," "minimally active," and "highly active" (Saglam et al., 2010).
Measured: at baseline
Pregnancy Exercise Self-Efficacy Questionnaire
This 10-item questionnaire assesses pregnant women's perceived ability and motivation to engage in physical activity under various circumstances. Adapted from the Exercise Self-Efficacy Scale, it was developed by Brand et al. to explain and predict changes in exercise behavior. A 5-point Likert scale is used (1 = strongly disagree to 5 = strongly agree), with total scores ranging from 10 to 50. Scores are categorized as follows: low self-efficacy, 10-17 points; moderate self-efficacy, 18-34 points; high self-efficacy, 35-50 points (Brand et al., 2013). The Turkish validity and reliability study was conducted by Üzelpasaci et al. (2023), with a Cronbach's alpha of 0.889.
Measured: at baseline
Visual Analog Scale (VAS) for Kinesiophobia
The severity of kinesiophobia among pregnant participants will be assessed using a vertical 0-10 cm Visual Analog Scale through the following question:
- "I am afraid that exercising during pregnancy might harm my baby" (0 = not afraid at all, 10 = extremely afraid)
Participants will be asked to mark a point on the VAS, and the distance from 0 will be measured with a ruler.
Measured: at baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Aug 2025
- Study start1 Sep 2025
- Primary completion25 Nov 2025
- Study completion1 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PregnancyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 300 participants (actual)
- Target duration
- 5 Days
Sponsor and investigators
- Lead sponsor
- Ordu University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Semiha Yenişehir, Ordu University
- Investigators
- Semiha Yenişehir, Principal investigator, Ordu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07134959
- Sponsor's protocol ID
- E-1146814
- Status last verified
- Jan 2026
- First submitted
- 14 Aug 2025
- Last updated
- 22 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validity and Reliability of Turkish Version Exercise Benefits/Barriers Scale in Pregnant Women
- ClinicalTrials.gov ID
- NCT07134959
- Acronym / sponsor ID
- E-1146814
- Conditions
- Pregnancy
- Keywords
- pregnancy, exercise, Questionnaire, physical activity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 300 participants (actual)
- Lead sponsor
- Ordu UniversityUniversity, hospital or other
- Study start
- 1 Sep 2025 (actual)
- Primary completion
- 25 Nov 2025 (actual)
- Study completion
- 1 Dec 2025 (actual)
- First posted
- 21 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to examine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women. It will contribute to raising awareness about engaging in physical activity and exercise during pregnancy in the pregnant population through the applied questionnaires.
Detailed description
Regular physical activity (PA) and exercise during pregnancy help protect the health of both the mother and the baby by reducing the risk of excessive gestational weight gain, hypertension, gestational diabetes, venous problems, and birth-related complications. They also have positive effects on sleep, stress, anxiety, depression, and overall quality of life. However, PA participation rates during pregnancy are low and tend to decline as pregnancy progresses through the trimesters. Hormonal and physiological changes, weight gain, fatigue, and psychological disturbances are among the main factors limiting participation. Therefore, identifying the barriers to PA during pregnancy and developing strategies to address them is essential. Assessing perceptions of the benefits and barriers to exercise can guide interventions aimed at increasing PA levels. This study aims to determine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women, with the expectation that its findings will provide valuable evidence for both scientific research and clinical practice.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 5 Days
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| study group | – | –pregnant women |
| control group | – | –healthy non-pregnant women |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Ordu University Training and Research Hospital
Key inclusion criteria (8 listed)
- Being between 18 and 45 years of age,
- Being in the second or third trimester of pregnancy,
- Being literate in Turkish,
- Willingness to participate in the study.
- Being between 18 and 45 years of age,
Key exclusion criteria (10 listed)
- Presence of pregnancy complications that may prevent physical activity and exercise (e.g., preeclampsia, vaginal bleeding, heart disease),
- Presence of orthopedic or neurological problems that may hinder participation in the study,
- Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
- Multiple pregnancy.
- Having a disease severe enough to prevent physical activity and exercise (e.g., endocrine and metabolic disorders, cardiopulmonary diseases),
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Exercise Benefits/Barriers Scale (EBBS):
Time frame: At baseline and 5 days after the first assessment
Developed in 1987 by Sechrist et al. to assess individuals' perceptions of the benefits of and barriers to exercise (Sechrist et al., 1987). It is a Likert-type scale with responses rated from "4 = strongly agree" to "1 = strongly disagree." The scale consists of two subscales: EBBS-Benefits and EBBS-Barriers. The EBBS-Benefits subscale contains 29 items, while the EBBS-Barriers subscale contains 14 items. In the EBBS-Barriers subscale, lower scores indicate a higher perceived barrier to exercise, whereas in the EBBS-Benefits subscale, higher scores indicate a more positive perception of exercise. The validity and reliability of the Turkish version were demonstrated by Saraç et al. (2024), with Cronbach's alpha coefficients of 0.95 for the EBBS-Benefits subscale and 0.82 for the EBBS-Barriers subscale (Saraç et al., 2024).
5 secondary outcomes
Barriers to Physical Activity During Pregnancy Scale
Time frame: at baseline
Pregnancy Physical Activity Questionnaire (PPAQ)
Time frame: at baseline
International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Time frame: at baseline
Pregnancy Exercise Self-Efficacy Questionnaire
Time frame: at baseline
Visual Analog Scale (VAS) for Kinesiophobia
Time frame: at baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Pregnancy
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
Active, not recruitingPhase 2
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor
Not yet recruiting
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Adenomyosis, Adenomyoma of Uterus
RecruitingPhase 2
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Chronic Kidney Disease
Not yet recruiting
Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b
Chronic Kidney Disease Stage 3A, Chronic Kidney Disease Stage 3B
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Semiha Yenişehir principal investigator
Ordu University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pregnancy, run by Ordu University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Exercise Benefits/Barriers Scale (EBBS): (time frame: At baseline and 5 days after the first assessment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.